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Introduction
Experiments were carried out in an In Vitro model of
CSF flow through VP shunts (Medtronic Inc) to investi-
gate the influence of three factors on shunt function:
1) CSF protein concentration; 2) CSF contamination
and; 3) Time of shunt incubation in the artificial CSF.
Methods
Two components of a shunt were tested separately: 1)
Ventricular catheter and; 2) Medium pressure, non-
programmable valve connected to a peritoneal cathe-
ter. In the “sterile” artificial CSF groups, each shunt
was incubated in one of six different sterile solutions
of varying protein conc. (0.5 g/l - normal and 1.0, 2.0,
5.0, 10.0 and 20 g/L), prepared by adding egg protein
(“Naturegg” Egg Whites; 1g/9ml) to normal saline, and
incubated in sterile artificial CSF for periods of 0, 7, 14
and 46 days.
A “Contaminated” group of shunts were similarly pre-
pared but exposed to skin microbes by handling them
with ungloved hands and incubating them in contami-
nated artificial CSF. The same contaminated CSF solu-
tions were used over the total 46 days of incubation but
only 3 different protein conc. (0.5, 5.0 and 20.0 g/L)
were prepared.
Both the sterile and contaminated shunts were tested
after four different incubation periods (0, 7, 14, 46 days).
Each of the two shunt components (1. Ventricular and;
2. Valve/peritoneal catheter) were tested separately by
connecting them with I.V. tubing to a manometer, all
filled with the test CSF. The manometer was prefilled to
a height of 30 cm H20 and CSF was allowed to flow
through each shunt component. The elapsed time (s)
was recorded when the CSF passed each 5cm increment
from 30 to 0 cm H20 or until flow stopped above 0 cm.
On a few occasions, CSF did not drop from the 30 cm
level. This “shunt blockage” occurred only when testing
the valve / peritoneal catheter complex. Height of CSF
column (cm) was plotted against time and the best lin-
ear fit determined for each data set. The slope of each
curve approximated the average rate of CSF flow (cm/s).
Results
In this In Vitro model, CSF protein of 5g/L or higher
was the threshold level to adversely affect CSF flow
through the valve/peritoneal catheter component: Incu-
bation for 46 days in a protein conc. of 10 g/L or higher,
resulted in a 75% decrease in CSF flow rate (.07 cm/s)
and an elevated closing pressure of 11 cm H20, com-
pared to testing at day 0 in 0.5 g/L (rate = .30 cm/s; CP
= 6 cm H20). Microbial contamination did further slow
flow but only after 46 days incubation in CSF with a
protein conc. of greater then 5 g/L. Absence of cellular
and humoral mediators of inflammation in this artificial
CSF could be addressed in future studies by using CSF
from patients with proven shunt infection. Flow through
the ventricular catheter was not affected in any situation
in this model.
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